scholarly article | Q13442814 |
P2093 | author name string | Stulting RD | |
Kaufman HE | |||
Wilhelmus KR | |||
Barron BA | |||
Asbell PA | |||
Laibson PR | |||
Sugar J | |||
Jones DB | |||
Dawson CR | |||
Bacchetti P | |||
Hyndiuk RA | |||
Gee L | |||
P2860 | cites work | Pharmacokinetics of oral acyclovir (Zovirax) in the eye. | Q33643138 |
Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration | Q33645278 | ||
A comparison of local and systemic acyclovir in the management of herpetic disciform keratitis | Q33648007 | ||
The management of ocular herpes. | Q34700567 | ||
Trifluorothymidin-prophylaxis of dendritic keratitis in steroid-treated herpetic keratouveitis (author's transl) | Q39640920 | ||
Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis | Q46043424 | ||
Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis | Q46662608 | ||
A double-blind comparative trial of acyclovir and adenine arabinoside in combination with dilute betamethasone in the management of herpetic disciform keratitis | Q68942834 | ||
Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982 | Q69674144 | ||
Herpes Simplex Treatment with IDU and Corticosteroids | Q76483650 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
stromal keratitis | Q55785372 | ||
P304 | page(s) | 969-972 | |
P577 | publication date | 1996-11-01 | |
P1433 | published in | British Journal of Ophthalmology | Q13443571 |
P1476 | title | Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group | |
P478 | volume | 80 |
Q37202989 | A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages |
Q90068169 | Absence of Signal Peptide Peptidase, an Essential Herpes Simplex Virus 1 Glycoprotein K Binding Partner, Reduces Virus Infectivity In Vivo |
Q35363452 | Adaptive and innate transforming growth factor beta signaling impact herpes simplex virus 1 latency and reactivation |
Q54264680 | An M2 Rather than a TH2 Response Contributes to Better Protection against Latency Reactivation following Ocular Infection of Naive Mice with a Recombinant Herpes Simplex Virus 1 Expressing Murine Interleukin-4. |
Q24186663 | Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis |
Q24235637 | Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis |
Q41829545 | Binding of HSV-1 glycoprotein K (gK) to signal peptide peptidase (SPP) is required for virus infectivity |
Q64103603 | CCR2+ migratory macrophages with M1 status are the early-responders in the cornea of HSV-1 infected mice |
Q35138386 | CD8α dendritic cells drive establishment of HSV-1 latency |
Q36816198 | Clinical efficacy of oral ganciclovir for prophylaxis and treatment of recurrent herpes simplex keratitis |
Q40605924 | Coregulatory interactions among CD8α dendritic cells, the latency-associated transcript, and programmed death 1 contribute to higher levels of herpes simplex virus 1 latency |
Q33695351 | Exacerbation of corneal scarring in HSV-1 gK-immunized mice correlates with elevation of CD8+CD25+ T cells in corneas of ocularly infected mice |
Q58598629 | HSV-1 ICP22 suppresses CD80 expression by murine dendritic cells |
Q57038997 | HSV-1 latency and the kinetics of reactivation are regulated by a complex network of interactions between HVEM, its ligands (gD, BTLA, LIGHT and CD160) and LAT |
Q99630471 | In Vivo Corneal Microstructural Changes in Herpetic Stromal Keratitis: A Spectral Domain Optical Coherence Tomography Analysis |
Q38309348 | Inclusion of CD80 in HSV targets the recombinant virus to PD-L1 on DCs and allows productive infection and robust immune responses |
Q33717645 | Inhibitors of signal peptide peptidase (SPP) affect HSV-1 infectivity in vitro and in vivo |
Q37300339 | Interrelationship of Primary Virus Replication, Level of Latency, and Time to Reactivation in the Trigeminal Ganglia of Latently Infected Mice. |
Q33608342 | Involvement of STAT4 in IgG subtype switching and ocular HSV-1 replication in mice |
Q37099743 | Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice |
Q92453878 | Loss of ICP22 in HSV-1 Elicits Immune Infiltration and Maintains Stromal Keratitis Despite Reduced Primary and Latent Virus Infectivity |
Q36934005 | Lymphoid-related CD11c+ CD8alpha+ dendritic cells are involved in enhancing herpes simplex virus type 1 latency. |
Q35076764 | Mutations within the pathogenic region of herpes simplex virus 1 gK signal sequences alter cell surface expression and neurovirulence |
Q34344404 | Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity |
Q57476625 | Pathogenesis of herpes simplex keratitis: The host cell response and ocular surface sequelae to infection and inflammation |
Q36311038 | Prospects for developing an effective vaccine against ocular herpes simplex virus infection |
Q60305292 | Role of Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein K (gK) Pathogenic CD8 T Cells in Exacerbation of Eye Disease |
Q36994291 | Role of dendritic cells in enhancement of herpes simplex virus type 1 latency and reactivation in vaccinated mice |
Q91983853 | The Latency-Associated Transcript Inhibits Apoptosis via Downregulation of Components of the Type I Interferon Pathway during Latent Herpes Simplex Virus 1 Ocular Infection |
Q42143302 | The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus 1. |
Q37774015 | Understanding the role of aldose reductase in ocular inflammation |
Q98726066 | Update on Herpes simplex keratitis management |
Search more.